GNS Healthcare Announces Strategic Investment from Merck Global Health Innovation Fund

by GNS Healthcare | Jan 7, 2020 | Featured Posts, Press Releases

Merck GHI joins leading biopharma companies Amgen, BMS, Zambon Pharmaceuticals, and leading health plans Cigna, Cambia Health Solutions, Echo Health Ventures, Horizon Blue Cross of NJ, and Heritage Provider Network, as an investor in GNS Healthcare. CAMBRIDGE, Mass. –...

GNS Healthcare Raises $23 Million Led by Cigna Ventures

by GNS Healthcare | Jul 9, 2019 | Featured Posts, Press Releases

Cigna Ventures taps GNS’ technology and solutions to further advance whole person health for Cigna’s customers and clients Additional partners participating in recent funding round include Amgen Ventures, Celgene Corporation, Echo Health Ventures and Alexandria...

GNS Healthcare Chosen to Present  Discovery of New Clinical Predictors of Overall Survival in Metastatic Colorectal Cancer at ESMO 2019 in Collaboration with the Alliance for Clinical Trials in Oncology

by GNS Healthcare | Jul 2, 2019 | Press Releases

AI-driven in silico patients used to identify heterogeneous landscape of clinical predictors of overall survival in populations of patients with metastatic colorectal cancer. CAMBRIDGE, Mass.– [July 2, 2019] – GNS Healthcare (GNS), a leading precision medicine...

Scott Gottlieb to Keynote GNS Healthcare’s Precision Medicine Forum

by GNS Healthcare | Jun 3, 2019 | Press Releases

23rd FDA Commissioner to share his thoughts on the convergence of data and AI in the development and use of new medicines along with industry luminaries from biopharma, payers, and patient foundations CAMBRIDGE, Mass., June 3, 2019 /PRNewswire/ — GNS Healthcare...

Business Health Care Group of Wisconsin Partners with GNS Healthcare to Improve Value of Care Across State

by GNS Healthcare | May 29, 2019 | Press Releases

Innovative use of causal artificial intelligence to reveal the practices of medicine that drive improved health outcomes at lower costs MILWAUKEE and CAMBRIDGE, Mass., May 29, 2019 — The Business Health Care Group (BHCG), a coalition of employers located...

GNS Healthcare Presents Results of Metastatic Colorectal Cancer Collaboration with the Alliance for Clinical Trials in Oncology at ESMO 2018

by GNS Healthcare | Oct 22, 2018 | Press Releases

Study identifies clinical and molecular drivers of survival at baseline to allow better risk stratification at initiation of treatment CAMBRIDGE, Mass.– [October 22, 2018] – GNS Healthcare (GNS), a leading precision medicine company, presented results in metastatic...